Growing geriatric population, increasing disposable income and rising life expectancy are expected to boost the market of Artificial Kidney Market. Kidney disease is the 9th leading cause of death in the country. According to the National Kidney Foundation around 10% of the population is suffering from chronic kidney diseases globally. Artificial Kidney refers to a device used to filter the blood of the person suffering from kidney damage. It is also known as haemodialyzer. The artificial kidney replicates the work of real kidney and eliminated the need of for dialysis. It helps to produce the hormone, regulate blood pressure, promote red cell and support bone health. It reduces the kidney disease and allows the patient to stay quality life.This growth is primarily driven by Rising Pool of Patients Suffering From Kidney Damage Owing to Aging & Age Related Disorder, Rising In the Disposable Income and Rise in Number of People Awaiting Organ Transplant.
Globally, a noticeable market trend is evident Technology Advancement in Field Of Science. Major Players, such as Baxter International Inc. (United States), Xcorporeal Inc. (United States), Medtronic, (United States), DaVita Inc. (United States), Merit Medical Systems, Inc. (United States), NIPRO Medical Corporation (United States), NxStage (United States), SynCardia Systems (United States), B. Braun Melsungen AG (Germany) and Fresenius (Germany) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
According to the National Kidney Foundation, " Around 10% of the population are suffering from chronic kidney diseases globally. About two million patients are either under the treatment of dialysis or need a kidney transplant to stay alive." In the global geriatric population, age between 65 to 74, it is predicted that one in five men and one in four women are suffering from chronic kidney diseases. About more than 30 Million American diseases.
Regulatory Insights:FDA approves the clinical testing of a wearable artificial kidney developed by the University of Washington Medical Center. Going forward, wearable artificial kidney systems are expected to be portable, lightweight, user-friendly, smaller, and more convenient.
- Rising Pool of Patients Suffering From Kidney Damage Owing to Aging & Age Related Disorder
- Rising In the Disposable Income
- Rise in Number of People Awaiting Organ Transplant
- Technology Advancement in Field Of Science
- High Cost of Artificial Kidney Hamper Broader Adoption
OpportunitiesGrowing Awareness about Artificial Kidney
ChallengesLack of Surgical Expertise
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the ReportAMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Artificial Kidney Study Sheds Light on The Artificial Kidney Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Artificial Kidney industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Artificial Kidney industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.